期刊文献+

EpCAM抗体偶联纳米磁珠阳性分离实体瘤外周血循环肿瘤细胞方法的建立 被引量:6

A new isolation method for peripheral blood circulating solid tumor cells with EpCAM antibody- linked nanobeads
原文传递
导出
摘要 目的建立EpCAM抗体偶联纳米磁珠阳性分离上皮来源的实体瘤外周血CTC的方法(简称“磁珠分离法”),探讨该方法分离CTC的灵敏度和应用意义。方法用7.5ml健康志愿者外周血裂解红细胞分别倍比稀释加入5、10、20、50、100个乳腺癌细胞系MCF7、食管癌细胞系KYSE70、胰腺癌细胞系BxPC-3及胃癌细胞系9811P,通过磁珠分离法富集癌细胞,荧光显微镜下检测体外加入癌细胞的回收率。然后,用磁珠分离法富集未治疗的30例食管癌(Ⅰ期+Ⅱ期6例、Ⅲ期+Ⅳ期24例)、35例乳腺癌(Ⅰ期+Ⅱ期15例、Ⅲ期+Ⅳ期20例)、30例胰腺癌(Ⅰ期+Ⅱ期5例、Ⅲ期+Ⅳ期25例)、33例胃癌患者(Ⅰ期+Ⅱ期13例、Ⅲ期+Ⅳ期20例)和30例慢性胃炎及30名健康志愿者的CTC,同时结合ⅠF和HE染色鉴定各组的CTC。另外,用FISH分别检测分析食管癌、乳腺癌、胰腺癌、胃癌患者200个CTC中8号和20号染色体拷贝数水平。结果用4,6-二眯-2苯吲哚(DAPⅠ)染色食管癌、乳腺癌、胰腺癌、胃癌等4种癌细胞系并加入健康志愿者7.5ml外周血的组内试验中,荧光显微镜下计数4种癌细胞的组内的平均回收率分别为87%、87%、86%和88%;5种稀释梯度的细胞数在4种癌细胞系的组问的平均回收率分别是88%、85%、87%、88%和87%。在10^7的外周血白细胞中能富集到1个癌细胞。采用磁珠分离法从食管癌、乳腺癌、胰腺癌及胃癌患者中检出≥2个CTC的阳性率分别为50%(15/30)、63%(22/35)、70%(21/30)及61%(20/33),健康志愿者和炎症患者均未检出CTC。食管癌、乳腺癌、胰腺癌组分别与健康对照组和炎症组比较,经精确概率法分析,差异均有统计学意义(P值均为0.000)。80%的食道癌、75%的乳腺癌、65%的胰腺癌和59%的胃癌患者CTC中均发生8号和20号染色体非整倍体改变。结论建立的磁珠分离法对富集分离实体瘤外周血CTC具有较好的分选灵敏度和准确性。食道癌、乳腺癌、胰腺癌和胃癌患者中的CTC多发生8号和20号染色体非整倍体改变。 Objective To establish an isolation method for solid CTC in peripheral blood using EpCAM antibody-linked nanobeads and evaluate the sensitivity of the method and its application significance. Methods Five, ten, twenty, fifty and one hundred MCF7 (breast cancer), KYSE70 (esophageal cancer), BxPC-3 (pancreatic cancer) and 9811P (stomach cancer) cells were added into 7. 5 ml erythrocyte lysed peripheral blood obtained from healthy volunteers respectively. EpCAM antibody- linked nanobeads were used to enrich cancer cells. The recovery rates of the in vitro added cancer cells were evaluated by fluorescence microscopy. Then, the untreated thirty cases of esophageal cancer ( six cases at stage Ⅰ and Ⅱ , twenty-four cases at stage m and IV), thirty-five cases of breast cancer (fifteen cases at stage Ⅰ and Ⅱ , twenty cases at stage Ⅲ and Ⅳ ), thirty cases of pancreatic cancer (five cases at stage I and Ⅱ , twenty-five cases at stage Ⅲ and Ⅳ), thirty-three gastric cancer (thirteen cases for stage Ⅰ and Ⅱ ,twenty cases at stage Ⅲand Ⅳ ) were enrolled to enrich the peripheral blood CTC. Thirty healthy volunteers and thirty gastritis patients served as two groups of control. Meanwhile the enriched CTC was identified by IF and HE staining. FISH was used to analyze the copy number of chromosome 8 and chromosome 20 in two hundred esophageal cancer, breast cancer, pancreatic caner and gastric cancer CTC. Results After DAPI staining and mixing with 7. 5 ml peripheral blood from healthy donors, the average cell recovery rates of KYSET0, MCFT, BxPC-3 and 9811P cells evaluated under fluorescence microscope were 87%, 87% , 86% and 88% (within group) , and the recovery rates of 5 gradient dilution levels were 88% , 85%, 87%, 88% and 87% (intergroup). With a high sensitivity, this method was able to isolate one cancer cell in 107 white blood cells of peripheral blood. The positive rates of more than 2 CTC in the peripheral blood detected by this method were 50% (15/30) of esophageal cancer, 63% (22/35) of breast cancer, 70% (21/30) of pancreatic cancer and 61% (20/33) gastric cancer patients respectively, but no CTC was detected in the peripheral blood of healthy volunteers and gastritis patients (P = 0. 000). The aneusomy of chromosome 8 and chromosome 20 were found in 80% esophageal cancer, 75% breast cancer, 65% pancreatic cancer and 59% gastric cancer. Conclusions The CTC isolation technique with EpCAM antibody-linked nanobeads is sensitive and accurate. The aneusomy of chromosome 8 and 20 is frequent in CTC from esophageal cancer, breast cancer, pancreatic cancer and gastric cancer.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2011年第3期218-223,共6页 Chinese Journal of Laboratory Medicine
关键词 抗原 肿瘤 细胞黏附分子 纳米粒子 肿瘤循环细胞 细胞系 肿瘤 Antigens, neoplasm Cell adhesion molecules Nanoparticles Neoplasm circulating cells Cell line,tumor
  • 相关文献

参考文献7

  • 1Husemlann Y, Geigl JB, Schubert F, et al. Systemic spread is an early step in breast cancer. Cancer Cell, 2008,13:58-68.
  • 2Maheswaran S, Haber DA. Circulating tumor cells : a window into cancer biology and metastasis. Curr Opin Genet Dev, 2010,20: 96-99.
  • 3Ring A, Smith IE, Dowsett M. Circulating tumour cells in breast cancer. Lancet Oncol, 2004,5:79-88.
  • 4Deng G, Herrler M, Burgess D, et al. Enrichment with anti- cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res, 2008,10 : R69.
  • 5Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res, 2004,10:6897-6904.
  • 6Fehm T, Sagalowsky A, Clifford E, et al. Cytogenetic evidence that circulating epithelial ceils in patients with carcinoma are malignant. Clin Cancer Res, 2002, 8:2073-2084.
  • 7任传利,何平,张金强,乔媛媛,王伟,周兰萍,文峰,赵平,赵晓航.8号和20号染色体拷贝数改变辅助食管癌外周血循环肿瘤细胞鉴定[J].中国肿瘤,2008,17(6):513-517. 被引量:9

二级参考文献14

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006 [J]. CA Cancer J Clin, 2006, 56(2): 106-130.
  • 2Cristofanilli M, Budd GT, Ellis M J, et al.Circulating tumor cells, disease progression, and survival in metastatic breast cancer[J]. N Engl J Med, 2004, 351(8):781-791.
  • 3Mocellin S, Keilholz U, Rossi CR, et al. Circulating tumor cells: the 'leukemic phase' of solid cancers[J]. Trends Mol Med, 2006, 12(3): 130-139.
  • 4Liu Z,Jiang M,Zhao J, et al. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility [J]. Clin Cancer Res, 2007, 13(10):2992-2997.
  • 5Fehm T, Sagalowsky A, Clifford E, et al. Cytogenetic evidence that cireulating epithelial cells in patients with carcinoma are malignant[J]. Clin Cancer Res, 2002, 8(7):2073-2084.
  • 6Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases[J]. Clin Cancer Res, 2004, 10(20):6897-6904.
  • 7Wang Q, Xu Y, Zhao X, et al. A facile one-step in situ functionalization of quantum dots with preserved photoluminescence for bioconjugation[J]. J Am Chem Soc, 2007, 129(20):6380-6381.
  • 8Wang B, Hendricks DT, Wamunyokoli F, et al. A growthrelated oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer[J]. Cancer Res, 2006, 66(6):3071-3077.
  • 9Okumura T, Tsunoda S, Mori Y, et al. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma[J]. Clin Cancer Res, 2006, 12 (17):5096-5103.
  • 10Ashworth A. A case of cancer in which cells similar to those in the tumours were seen in the blood afler death[J]. Aust Med J, 1869, 14:146.

共引文献8

同被引文献109

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部